Cargando…

Canagliflozin-associated diabetic ketoacidosis: a case report

Canagliflozin is a novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor approved for the management of diabetes. We report the presentation and management of two cases of canagliflozin associated diabetic ketoacidosis (DKA) and discuss the mechanism of canagliflozin associated DKA. Patient 1, a 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Peter R., Bonney, Caitlin, Blohm, Eike, Boyer, Edward W., Babu, Kavita M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029867/ https://www.ncbi.nlm.nih.gov/pubmed/29978156 http://dx.doi.org/10.1080/24734306.2017.1331604

Ejemplares similares

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature
por: Turner, Jessica, et al.
Publicado: (2016)

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report
por: Fukuda, Masafumi, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
por: Adachi, Junichiro, et al.
Publicado: (2017)

Canagliflozin-associated Diabetic Ketoacidosis with Lower-than-anticipated Glucose Levels
por: Vadi, Sonali, et al.
Publicado: (2017)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
por: Erondu, Ngozi, et al.
Publicado: (2015)

Severe Ketoacidosis Associated with Canagliflozin (Invokana): A Safety Concern
por: Gelaye, Alehegn, et al.
Publicado: (2016)

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
por: Kelmenson, Daniel A., et al.
Publicado: (2017)

Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report
por: Bowman, Christopher, et al.
Publicado: (2017)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report
por: Earle, Matthew, et al.
Publicado: (2020)

SUN-183 Prolonged Glycosuria after Canagliflozin Discontinuation in a Patient with Euglycemic Diabetic Ketoacidosis
por: Dai, Yufei, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis Accompanied by Severe Hypophosphatemia During Recovery in a Patient With Type 2 Diabetes Being Treated With Canagliflozin/Metformin Combination Therapy
por: Shoukat, Sonia, et al.
Publicado: (2017)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Brentuximab vedotin-associated diabetic ketoacidosis: a case report
por: Köksalan, Damla, et al.
Publicado: (2022)

Cerebral edema associated with diabetic ketoacidosis: Two case reports
por: Namatame, Kaoru, et al.
Publicado: (2023)

Delirium in Diabetic Ketoacidosis: A Case Report
por: Nurcan Cebeci, Ayşe, et al.
Publicado: (2012)

Diabetic ketoacidosis with pneumomediastinum: a case report
por: Makdsi, Fadi, et al.
Publicado: (2009)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2020)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2022)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin
por: Bader, Nimrah, et al.
Publicado: (2016)

An Exceptional Case of Diabetic Ketoacidosis
por: Van de Vyver, Celine, et al.
Publicado: (2017)

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice
por: Woo, Vincent, et al.
Publicado: (2018)

Severe Hypercalcemia in Diabetic Ketoacidosis: A Case Report
por: Makaya, Tafadzwa, et al.
Publicado: (2013)

Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis: 2 case reports
Publicado: (2021)

Empagliflozin/linagliptin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Ipragliflozin/tozinameran: Diabetic ketoacidosis: 2 case reports
Publicado: (2022)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases
por: Singh, Balraj, et al.
Publicado: (2021)

AZD-1222: Hyperglycaemic ketosis, mixed hyperglycaemic hypermolar state/diabetic ketoacidosis and diabetic ketoacidosis: 3 case reports
Publicado: (2021)

The diabetic ketoacidosis
por: Cardella, Francesca
Publicado: (2014)

Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis
por: Thawabi, Mohammad, et al.
Publicado: (2015)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

Emerging treatments in type 2 diabetes: focus on canagliflozin
por: Rosiak, Marek, et al.
Publicado: (2014)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
por: Triplitt, Curtis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hgcmkp01dfqvbgbeojk498ac2i